These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 12522728

  • 1. [Aprotinin -- an allogeneic transfusion sparing drug].
    Haas S.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):38-40. PubMed ID: 12522728
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Aprotinin in the control of surgical hemorrhage].
    Rocha E, Antonio Páramo J, Hermida J.
    Med Clin (Barc); 1996 Mar 02; 106(8):307-16. PubMed ID: 8667690
    [No Abstract] [Full Text] [Related]

  • 7. Reducing allogeneic transfusion in cardiac surgery.
    Tempe DK.
    Br J Anaesth; 2005 Aug 02; 95(2):277-8. PubMed ID: 16006659
    [No Abstract] [Full Text] [Related]

  • 8. Aprotinin may decrease blood loss in complex adult spinal deformity surgery, but it may also increase the risk of acute renal failure.
    Okubadejo GO, Bridwell KH, Lenke LG, Buchowski JM, Fang DD, Baldus CR, Nielsen CH, Lee CC.
    Spine (Phila Pa 1976); 2007 Sep 15; 32(20):2265-71. PubMed ID: 17873821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Aprotinin in cardiac surgery: one paper of the year or a provocation from the New England Journal of Medicine].
    Blanloeil Y.
    Ann Fr Anesth Reanim; 2006 Jul 15; 25(7):683-5. PubMed ID: 16919751
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T, Jares M, Fajt R, Straka Z, Jirasek K, Kolesar M, Brucek P, Maly M.
    Eur J Cardiothorac Surg; 2005 Oct 15; 28(4):563-8. PubMed ID: 16125959
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is aprotinin safe when used in the context of profound hypothermia and circulatory arrest? A literary review.
    Hornick P, Taylor KM.
    J Heart Valve Dis; 1995 Nov 15; 4(6):669-73. PubMed ID: 8611984
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Body SC, Mazer CD.
    Anesth Analg; 2006 Dec 15; 103(6):1354-9. PubMed ID: 17122202
    [No Abstract] [Full Text] [Related]

  • 20. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
    Hill SE.
    J Cardiothorac Vasc Anesth; 2007 Apr 15; 21(2):298-301. PubMed ID: 17418753
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.